fda approved glp-1 gip medications 2025 Oral semaglutide (Rybelsus) is the 4th receptor agonist formulation to receive approval to reduce the risk of major cardiovascular events in patients with type 2 diabetes. Our GLP-1 Agonist chart Tirzepatide vs. Semaglutide: What You

The impact of GLP-1 RAs on lipid synthesis and oxidation in the liver, resulting in decreased inflammation and fibrosis, has led to studies evaluating their potential for the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), and inflammatory bowel disease (IBD), and the prevention of hepatobiliary and other gastrointestinal (GI) cancers [1,5]

In some cases doctors may recommend dietary changes or medications to treat underlying digestive disorders

Then his doctor started him on Mounjaro (tirzepatide)

Many patients taking GLP-1 receptor agonists for diabetes or weight management report improvements in joint pain, prompting questions about whether these medications directly address musculoskeletal symptoms

npj Digit

All of a sudden theyd quit smoking, Yammine recalled in an interview